SCHEMBL29180229

SCHEMBL29180229

CC(=O)OCCOCCOc1ccc(-c2cc(=O)c3ccc(Br)c(Cl)c3o2)cc1

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 7/20 0.48
▸ ABCB1 P08183 4/20 0.48
▸ ABCC1 P33527 1/20 0.48
▸ BCHE P06276 3/20 0.45
▸ CNR2 P34972 3/20 0.45
▸ HDAC3 O15379 1/20 0.42
▸ HDAC4 P56524 1/20 0.42
▸ HDAC1 Q13547 1/20 0.42
▸ HDAC2 Q92769 1/20 0.42
▸ HDAC6 Q9UBN7 1/20 0.42
▸ ALDH2 P05091 1/20 0.41
▸ MAOA P21397 1/20 0.41
▸ MAOB P27338 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26607921 0.86 ABCB1 (0.47) ABCG2ABCB1ABCC1BCHECNR2
SCHEMBL21801256 0.86 KDM4E (0.50) ABCG2ABCB1ABCC1BCHECNR2
SCHEMBL21801307 0.78 CYP1A1 (0.60) ABCG2ABCB1ABCC1MAOB
SCHEMBL30744123 0.78 CYP1A1 (0.60) ABCG2ABCB1ABCC1MAOB
SCHEMBL21801234 0.78 HDAC3 (0.40) ABCG2ABCB1ABCC1BCHEHDAC3
SCHEMBL30744124 0.78 HDAC3 (0.40) ABCG2ABCB1ABCC1BCHEHDAC3
SCHEMBL21801175 0.74 TERT (0.62) BCHEMAOAMAOB
SCHEMBL30744111 0.74 TERT (0.62) BCHEMAOAMAOB
SCHEMBL21801309 0.72 ABCB1 (0.52) ABCG2ABCB1ABCC1BCHECNR2
SCHEMBL21801150 0.71 ABCB1 (0.56) ABCG2ABCB1ABCC1BCHECNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112601743-B Flavone compounds for the treatment and prevention of hepatitis b virus diseases 豪夫迈·罗氏有限公司 2023-12-19 — — CN claimed
CN-112601743-B Flavone compounds for the treatment and prevention of hepatitis b virus diseases 豪夫迈·罗氏有限公司 2023-12-19 — — CN disclosed
Send feedback